BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan · Delayed Price · Currency is TWD 42.70
+0.10 (0.23%)
Oct 9, 2025, 1:30 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 5.31 billion as of October 10, 2025. Its market cap has increased by 16.67% in one year.
Market Cap
5.31B
Enterprise Value
4.76B
Revenue
195.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.70
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 5.31B, an increase of 95.48%. That is a compound annual growth rate of 11.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 5.31B | 26.89% |
| Dec 31, 2024 | 4.18B | -11.18% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | 3.57B | 46.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 199.34B |
| Bora Pharmaceuticals Co., LTD. | 81.67B |
| Lotus Pharmaceutical | 74.03B |
| Lumosa Therapeutics | 45.48B |
| Oneness Biotech | 31.09B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |